Márquez MF

Language: Spanish
References: 16
Page: 126-129
PDF size: 73.94 Kb.

ABSTRACT

There is a subset of patients with neurocardiogenic syncope among whom syncopal recurrences are frequent and without prodromic symptoms, or have a traumatic outcome. For this subgroup the term “malignant neurocardiogenic syncope” has been proposed. Frequently, these patients suffer from syncopes that are accompanied by profound bradycardia and prolonged asystole (more than 5 seconds). Although in the literature the term malignant is used as equal to syncope with prolonged asystole, this practice could lead to prognostic and therapeutic errors. The present article describes its clinical features, the usefulness of head-up tilt test for its therapeutic evaluation, and the wide variety of treatments that have been proposed including beta-adrenergic blockade, DDD pacemakers, and repeated tilt training program.

REFERENCES

1. Engel GL: Psychological stress, vasodepressor (vasovagal) syncope, and sudden death. Ann Intern Med 1978; 89: 403-412.

2. Sutton R: Vasovagal syndrome-could it be malignant? Eur J Cardiac Pacing Electrophysiology 1992; 2: 89.

3. Koga T, Kaseda S, Miyazaki N, Kawazoe N, Abe Y, Sadoshima S, et al: Neurally mediated syncope induced by lung cancer-a case report. Angiology 2000; 51: 263-267.

4. Angelini P, Holoye PY: Neurocardiogenic syncope and Prinzmetal’s angina associated with bronchogenic carcinoma. Chest 1997; 111: 819-822.

5. Brugada P, Brugada J, Brugada R: The yet unresolved dilemma of syncope in Brugada syndrome. Europace 2001; 3: 157-158.

6. Samniah N, Iskos D, Sakaguchi S, Lurie G, Benditt DG: Syncope in pharmacologically unmasked Brugada syndrome: indication for an implantable defibrillator or an unresolved dilemma? Europace 2001; 3: 159-163.

7. Hermosillo AG, Falcón JC, Márquez MF, Arteaga D, Cárdenas M: Positive head-up tilt table test in patients with the long QT syndrome. Europace 1999; 1: 213-217.

8. Hermosillo AG, Márquez MF, Jáuregui-Renaud K, Falcón JC, Casanova JM, Guevara M, et al: Tilt testing in neurocardiogenic syncope: isosorbide versus isoproterenol. Acta Cardiológica 2000; 55: 351-355.

9. Biffi M, Boriani G, Sabbatani P, Bronzetti G, Frabetti L, Zannolio R, et al: Malignant vasovagal syncope: a randomized trial of metoprolol and clonidine. Heart 1997; 77: 268-272.

10. Kouakam C, Lacroix D, Klug D, Ben Ameur Y, Guedon-Moreau L, Kacet S, et al: Determinants of malignant vasovagal syncope with asystole disclosed by the tilting test and therapeutic implications. Ann Cardiol Angeiol 1997; 46: 135-143.

11. Kosinski D, Grubb BP, Elliott L, Dubois B: Treatment of malignant neurocardiogenic syncope with dual chamber cardiac pacing and fluoxetine hydrochloride. Pacing Clin Electrophysiol 1995; 18: 1455-1457.

12. Abe H, Iwami Y, Nagatomo T, Miura Y, Nakashima Y: Treatment of malignant neurocardiogenic vasovagal syncope with a rate drop algorithm in dual chamber cardiac pacing. Pacing Clin Electrophysiol 1998; 21: 1473-1475.

13. Van Dijk N, Velzeboer SC, Destree-Vonk A, Linzer M, Wieling W: Psychological treatment of malignant vasovagal syncope due to bloodphobia. Pacing Clin Electrophysiol 2001; 24: 122-124.

14. Numata T, Abe H, Nagatomo T, Sonoda S, Kohshi K, Nakashima Y: Successful treatment of malignant neurocardiogenic syncope with repeated tilt training program. Jpn Circ J 2000; 64: 406-409.

15. Reybrouck T, Heidbuchel H, Van de Werf F, Ector H: Tilt training: a treatment for malignant and recurrent neurocardiogenic syncope. Pacing Clin Electrophysiol 2000; 23: 493-498.

16. Hart PS, Yanny W: Needle phobia and malignant vasovagal syndrome. Anesthesia 1998; 53: 1002-1004.